Charlie Strange to Middle Aged
This is a "connection" page, showing publications Charlie Strange has written about Middle Aged.
Connection Strength
0.766
-
Prevalence of self-reported sleep problems amongst adults with obstructive airway disease in the NHANES cohort in the United States. Sleep Breath. 2020 Sep; 24(3):985-993.
Score: 0.050
-
Sequencing Alpha-1 MZ Individuals Shows Frequent Biallelic Mutations. Pulm Med. 2018; 2018:2836389.
Score: 0.046
-
Proteomic biomarkers of cognitive impairment in obstructive sleep apnea syndrome. Sleep Breath. 2019 Mar; 23(1):251-257.
Score: 0.046
-
Mortality in Asthma-Chronic Obstructive Pulmonary Disease Overlap in the United States. South Med J. 2018 05; 111(5):293-298.
Score: 0.045
-
Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States. Ann Am Thorac Soc. 2016 06; 13(6):803-10.
Score: 0.040
-
Gender and asthma-chronic obstructive pulmonary disease overlap syndrome. J Asthma. 2016 09; 53(7):720-31.
Score: 0.039
-
Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol. Ann Am Thorac Soc. 2015 Oct; 12(10):1551-60.
Score: 0.038
-
Smoking duration, respiratory symptoms, and COPD in adults aged =45 years with a smoking history. Int J Chron Obstruct Pulmon Dis. 2015; 10:1409-16.
Score: 0.037
-
The United States Alpha-1 Foundation Research Registry: Genesis, Impact and Future. COPD. 2015 May; 12 Suppl 1:42-5.
Score: 0.037
-
Impact of medications on cognitive function in obstructive sleep apnea syndrome. Sleep Breath. 2015 Sep; 19(3):939-45.
Score: 0.036
-
Genetics' influence on patient experiences with a rare chronic disorder: a photovoice study of living with alpha-1 antitrypsin deficiency. Nurs Clin North Am. 2013 Dec; 48(4):627-36.
Score: 0.033
-
Inhaled alpha 1-antitrypsin: gauging patient interest in a new treatment. COPD. 2013 Aug; 10(4):411-5.
Score: 0.032
-
A 56-year-old woman with arm pain, dyspnea, and an elevated diaphragm. Chest. 2008 Jan; 133(1):296-9.
Score: 0.022
-
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med. 2008 Jan 01; 177(1):91-8.
Score: 0.022
-
Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med. 2006 Dec; 34(12):2974-8.
Score: 0.020
-
Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration. 2006; 73(2):185-90.
Score: 0.019
-
Genetic testing for alpha1-antitrypsin deficiency. Genet Med. 2004 Jul-Aug; 6(4):204-10.
Score: 0.017
-
Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension. Chest. 2000 Oct; 118(4):1077-82.
Score: 0.013
-
Islet Harvest in Carbon Monoxide-Saturated Medium for Chronic Pancreatitis Patients Undergoing Islet Autotransplantation. Cell Transplant. 2019 Dec; 28(1_suppl):25S-36S.
Score: 0.013
-
Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy. Stem Cells Transl Med. 2018 01; 7(1):11-19.
Score: 0.011
-
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719.
Score: 0.010
-
Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial. JAMA. 2016 May 24-31; 315(20):2178-89.
Score: 0.010
-
A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis. Ann Am Thorac Soc. 2016 Mar; 13(3):342-9.
Score: 0.010
-
Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment. J Manag Care Spec Pharm. 2016 Mar; 22(3):293-304.
Score: 0.010
-
Patterns of Emphysema Heterogeneity. Respiration. 2015; 90(5):402-11.
Score: 0.009
-
Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments. Int J Chron Obstruct Pulmon Dis. 2015; 10:2055-66.
Score: 0.009
-
Impact of obstructive sleep apnea syndrome on cognition in early postmenopausal women. Sleep Breath. 2016 May; 20(2):621-6.
Score: 0.009
-
Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based Surveillance. COPD. 2015; 12(6):680-9.
Score: 0.009
-
Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population. Int J Chron Obstruct Pulmon Dis. 2015; 10:1417-25.
Score: 0.009
-
Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease. Respir Med. 2015 Jul; 109(7):851-9.
Score: 0.009
-
Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study. Respir Res. 2015 Apr 23; 16:52.
Score: 0.009
-
Effect of obstructive sleep apnea treatment on mail-in cognitive function screening instrument. Am J Med Sci. 2014 Sep; 348(3):215-8.
Score: 0.009
-
Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema. Chest. 2013 Nov; 144(5):1578-1586.
Score: 0.008
-
Rude awakening: acute abdominal pain with spontaneous resolution. Am J Med. 2012 Oct; 125(10):971-3.
Score: 0.008
-
Empiric auto-titrating CPAP in people with suspected obstructive sleep apnea. J Clin Sleep Med. 2010 Apr 15; 6(2):140-5.
Score: 0.006
-
Radiation therapy for palliation of Eisenmenger's syndrome-associated painful splenomegaly. Radiat Med. 2008 Feb; 26(2):84-7.
Score: 0.006
-
Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency. Ann Behav Med. 2007 Feb; 33(1):22-8.
Score: 0.005
-
Pneumothorax in cystic fibrosis. Chest. 2005 Aug; 128(2):720-8.
Score: 0.005